4. 2024 SABPA Frontiers in Therapeutics and Diagnostics (FTD) Meeting
---Exploring the Future of Therapeutics and Diagnostics: Unveiling Breakthroughs in Medicine
We are delighted to offer a sneak peek into the much-anticipated 2024 SABPA Frontiers in Therapeutics and Diagnostics (FTD) Meeting.
When: March 23, 2024
Where: Hilton San Diego/Del Mar
The forthcoming FTD Conference is set to shine a spotlight on three revolutionary domains: Glucagon-like peptide-1 (GLP-1), Antibody-Drug Conjugates (ADC), and Minimal Residual Disease (MRD), each representing the forefront of innovations in therapeutics and diagnostics.
- The realm of diabetes management is witnessing a paradigm shift with GLP-1 inhibitors, a class of drugs demonstrating remarkable efficacy in regulating blood sugar levels. We are thrilled to announce that Dr. Lotte Bjerre Knudsen, Chief Scientific Advisor at Novo Nordisk, will be our keynote speaker in this session.
- ADCs represent a formidable fusion of antibodies and potent drugs, orchestrating a targeted attack on specific cells while sparing healthy ones, enabling more precise and effective treatments for various cancers. The recent acquisition of Seagen by Pfizer marks a significant step forward in the advancement of ADC therapeutics. We are privileged to have the Chief Scientific Officer of Pfizer Oncology R&D, Dr. Jeff Settleman, as the keynote speaker to offer a glimpse into the scientific innovation and impact expected from integrating Seagen’s technology and expertise into Pfizer’s R&D pipeline.
- The concept of MRD has emerged as a game-changer in cancer therapeutics. By detecting and targeting residual cancer cells that may linger post-treatment, MRD assessments offer a clearer understanding of disease progression and treatment response.
In addition to our compelling lineup of presentations, the 2024 SABPA FTD Conference will feature a dynamic Poster Session, adding a unique dimension to the event.
Stay tuned for an event that promises the opportunity to immerse yourself in the latest scientific advancements, engage with promising researchers, and celebrate the achievements of our community.
Register now for the 2024 FTD Conference here and be part of a day filled with inspiration, collaboration, and recognition.
Call for Posters at the FTD Conference:
We extend an invitation to postdocs, graduate students, and research professionals from local institutes and universities to showcase their innovative research through poster presentations, fostering collaborations and sharing discoveries.
The poster session aims to be a vibrant hub of scientific exchange, providing attendees with the opportunity to engage with emerging talent and explore diverse perspectives.
To honor excellence in poster presentations, we are proud to introduce two awards: the Investigator Award and the Most Popular Award. These accolades celebrate outstanding contributions to the fields of therapeutics and diagnostics.
We encourage all participants to submit their posters for consideration and look forward to acknowledging the exceptional work of our local research community.
Best regards,
SABPA FTD Committee
|